On April 8, 10 of the 12 panel members voted that the intraocular lens was safe, effective and had benefits that outweighed its risks.
More Articles on Ophthalmology:
Researchers Find Possible Prevention of Retinal Detachment Side Effect
FDA Approves PROLENSA from Bausch + Lomb
Bausch + Lomb VICTUS Femtosecond Laser Earns CE Mark
FDA Ophthalmic Device Panel Advocates Bausch + Lomb Intraocular Lens
The Bausch + Lomb Trulign toric accommodating posterior chamber ocular lens has received premarket approval from the Ophthalmic Devices Panel of the FDA, according to a Medscape report.
BCBA state of the profession survey: Navigating urgent challenges and shaping the future
Recommended Whitepaper